LATHAM, N.Y.–(BUSINESS WIRE)–Jul. 29, 2021– AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular…
Read More
AngioDynamics, with its disruptive and innovative medical devices, addresses unmet patient needs by elevating the standard of care for chronic and acute disease states in vascular, peripheral vascular, and oncology medicine.
These devices provide healthcare professionals around the world with the vital tools they need to deliver high-quality patient care and improve patient outcomes.
“The acquisition of Auryon brings a remarkable, foundational technology to our portfolio that will change the way caregivers deliver treatment…
The BioFlo PICC is the first PICC of its kind with Endexo Technology, providing a catheter more resistant to the…
The Solero* Microwave Tissue Ablation (MTA) System and Accessories are indicated for the ablation of soft tissue during open procedures….
It takes a team of talented people to become one of the world’s leading providers of innovative medical devices.
The deep commitment and contributions of our employees helped to build a global company that’s pioneering new ways to improve patient outcomes.
If you find the idea of joining a dynamic team that’s dedicated to improving the lives of patients appealing, we invite you to review our available opportunities.
Pleased to be featured in the @AlbanyBizReview regarding our growth, investor confidence, and the outstanding work done by our entire global workforce.
https://www.bizjournals.com/albany/news/2021/04/21/ceo-on-why-investors-believe-in-angiodynamics.html (subscription may be required)
Join AngioDynamics' Vascular Access team at @WoCoVA. Visit the virtual booth and chat with staff to learn about new technologies and techniques in vascular access: http://bit.ly/WoCoVA21
Thank you to @EVToday for sharing the news about the FDA 510(k) submission for our off-circuit, multipurpose mechanical aspiration thrombectomy device. Read more! https://evtoday.com/news/angiodynamics-seeks-fda-clearance-of-alphavac-mechanical-thrombectomy-system
AngioDynamics is pleased to announce the submission of a 510(k) application to the U.S. FDA for the AlphaVac Mechanical Thrombectomy System:
AngioDynamics Submits 510(k) Application to FDA for AlphaVac Mechanical Thrombectomy System | AngioDynamics
The Investor Relations website contains information about AngioDynamics's business for stockholders, potential investors, and financial analysts.
bit.ly
AngioDynamics® history is best characterized by innovation and growth. Originally founded in Queensbury, N.Y., U.S., in 1988, AngioDynamics has grown into a NASDAQ-listed public company with a global reach.
Latham, NY (HQ)
Glens Falls, NY (Manufacturing)
Queensbury, NY (Manufacturing)
Marlborough, MA (R&D)
Amsterdam, NL (International HQ)
São Paulo, BR (Brazil Office)
Oakville, CA (Canada Office)
Hong Kong, HK (Asia Pacific Regional Office)
Rehovot, IL (Israel Office)
